Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Arnogene: A Phosphocalcic Study in Dialysis (ARNOGENE)

This study has been completed.
Sponsor:
Information provided by:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT00858260
First received: March 6, 2009
Last updated: September 3, 2009
Last verified: September 2009

March 6, 2009
September 3, 2009
November 2008
Not Provided
Assessing morbi-mortality based on Klotho variants [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00858260 on ClinicalTrials.gov Archive Site
Survival and serum phosphocalcic parameters [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Arnogene: A Phosphocalcic Study in Dialysis
Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients

Searching for high morbi-mortality risk Klotho variants in dialysis patients

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Searching for high morbi-mortality risk Klotho variants

Non-Probability Sample

Adult patients undergoing maintenance dialysis since at leat three months

Dialysis
Genetic: blood sample
Searching for Klotho variants in DNA
hemodialysis patients
Adult patients undergoing maintenance dialysis since at leat three months
Intervention: Genetic: blood sample
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1200
February 2009
Not Provided

Inclusion Criteria:

  • Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00858260
2007.471/14
No
Pr Denis FOUQUE, Hospices Civils de Lyon
Hospices Civils de Lyon
Not Provided
Principal Investigator: FOUQUE Denis, MD Hospices Civils de Lyon
Principal Investigator: LEGRAND Eric, MD CH Annonay
Principal Investigator: KAARASLAN Huseyin, MD CH Bourgoin Jallieu
Principal Investigator: ABOKASEM Ayman, MD CH Chalon/saône
Principal Investigator: LATAILLADE Claire Dominique, MD CH Sallanches
Principal Investigator: KUENTZ François, MD Centre Dialyse eaux claires
Principal Investigator: HACHACHE Toufic, MD CHU Grenoble - La Tronche
Principal Investigator: LEITIENNE Philippe, MD Hospices Civils de Lyon
Principal Investigator: ARKOUCHE Walid, MD AURAL - Lyon
Principal Investigator: HEYANI Ahmed, MD CH MACON
Principal Investigator: HANNOUN Jacques, MD CH Villefranche/saône
Principal Investigator: COMBARNOUS François, MD Clinique du Tonkin VILLEURBANNE
Principal Investigator: MAUREAUGANDRY Xavier, MD AGDUC - Montélimar
Principal Investigator: SIRAJEDINE Mohamed, MD CH ROMANS/ISERE
Principal Investigator: JEAN Ahmed, MD Centre du Rein - Tassin la demi lune
Principal Investigator: DENICOLA Cora, MD Calydial - CH Viennes
Hospices Civils de Lyon
September 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP